Literature DB >> 19452429

Perinatal (fetal and neonatal) tuberous sclerosis: a review.

Hart Isaacs1.   

Abstract

Tuberous sclerosis (TSC) is an autosomal-dominant disorder that presents with highly variable clinical manifestations including seizures, mental retardation, skin lesions, and hamartomas affecting multiple organ systems such as the heart, brain, eye, and kidney. A 42-year retrospective review of 70 patients consisting of 43 fetuses and 27 neonates with TSC were analyzed. There was a 16% positive family history for the disease. Obvious signs are present in the perinatal period. Cardiac rhabdomyoma(s) detected on routine antenatal sonography, arrhythmias, cerebral lesions, hydrops, and stillbirth are the major presenting findings in the fetus, whereas respiratory distress, arrhythmias, murmurs, and cardiomegaly are the main signs initially in the neonate. Cardiac rhabdomyomas comprised 32.8% of the TSC pathological findings; those of central nervous system origin, 47.5%; and renal cystic disease, 13.2%. Skin lesions and retinal hamartomas were noted rarely at birth. Of the 15 survivors, 87% developed a seizure disorder; 33%, residual cardiac rhabdomyomas; and 27%, mental retardation. The survival rates of patients diagnosed antenatally was practically the same as for those after birth, 21% and 22%, respectively. The overall survival was low, 15/70 or 21%. When TSC occurs in the perinatal period, it is associated with a high incidence of morbidity and mortality. (c) Thieme Medical Publishers.

Entities:  

Mesh:

Year:  2009        PMID: 19452429     DOI: 10.1055/s-0029-1223267

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  13 in total

1.  Fetal arrhythmias associated with cardiac rhabdomyomas.

Authors:  Annette Wacker-Gussmann; Janette F Strasburger; Bettin F Cuneo; Delonia L Wiggins; Nina L Gotteiner; Ronald T Wakai
Journal:  Heart Rhythm       Date:  2013-12-11       Impact factor: 6.343

2.  Deletion of tuberous sclerosis 1 in somatic cells of the murine reproductive tract causes female infertility.

Authors:  Yoshihiro Tanaka; Joo Hyun Park; Pradeep S Tanwar; Tomoko Kaneko-Tarui; Shilpi Mittal; Ho-Joon Lee; Jose M Teixeira
Journal:  Endocrinology       Date:  2011-11-29       Impact factor: 4.736

Review 3.  Molecular therapies for tuberous sclerosis and neurofibromatosis.

Authors:  David Neal Franz; Brian D Weiss
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

Review 4.  Imaging of fetal brain tumors.

Authors:  Patricia Cornejo; Tamara Feygin; Jennifer Vaughn; Cory M Pfeifer; Alexandra Korostyshevska; Mittun Patel; Dianna M E Bardo; Jeffrey Miller; Luis F Goncalves
Journal:  Pediatr Radiol       Date:  2020-11-30

Review 5.  Tuberous sclerosis complex: perioperative considerations.

Authors:  Matthew J Rabito; Alan David Kaye
Journal:  Ochsner J       Date:  2014

Review 6.  The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth.

Authors:  Sam Amin; Andrew Lux; Finbar O'Callaghan
Journal:  Br J Clin Pharmacol       Date:  2018-11-08       Impact factor: 4.335

Review 7.  Maternal Genetic Disorders in Pregnancy.

Authors:  Sarah Harris; Neeta L Vora
Journal:  Obstet Gynecol Clin North Am       Date:  2018-06       Impact factor: 2.844

8.  An unusual case of perinatal tuberous sclerosis.

Authors:  Deeparaj Ganapati Hegde; Jayashree Mondkar; Harshad Panchal
Journal:  J Clin Neonatol       Date:  2014-04

Review 9.  Perinatal (fetal and neonatal) astrocytoma: a review.

Authors:  Hart Isaacs
Journal:  Childs Nerv Syst       Date:  2016-08-27       Impact factor: 1.475

10.  Rapamycin therapy for neonatal tuberous sclerosis complex with cardiac rhabdomyomas: A case report and review.

Authors:  Shanshan Mao; Qi Long; Huijia Lin; Jinling Liu
Journal:  Exp Ther Med       Date:  2017-10-18       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.